The Executive Committee supports the Board of Directors by advising on decision-making processes, handling time-sensitive issues, and overseeing organizational policies, human resources, external relations, and strategic planning, with the authority to act on the Board's behalf within defined limitations.
Chair: Bruce Strober, United States, President
Members
Claudia de la Cruz, Chile, Vice President/President-Elect
Joel Gelfand, United States, Treasurer
Catherine Smith, United Kingdom, Secretary
Christy Langan, United States, CEO
The Finance Committee is tasked with overseeing the organization's financial health, ensuring the maintenance of accurate financial records, preparation of meaningful financial statements, budget oversight, asset protection, and compliance with financial regulations.
Chair: Joel Gelfand, USA, Treasurer
Members
Bruce Strober, United States, President
Andrew Blauvelt, United States
Lone Skov, Denmark
Christy Langan, United States, CEO
The Governance Committee evaluates and refines the organization's governance structures and practices, ensuring the Board's composition meets its diverse needs for effective duty fulfillment. Responsibilities include overseeing Board Member elections, assessing Board composition for diversity and expertise, developing governance policies, and ensuring consistency across the organization's mission, vision, and governing documents.
Chair: Catherine Smith, United Kingdom, Secretary
Members
Mahira El Sayed, Egypt
Johann Gudjonsson, United States
Bruce Strober, United States, President
Lluís Puig, Spain
Christy Langan, United States, CEO
The Membership Committee aims to enhance IPC's engagement by developing strategies to involve young professionals and underrepresented regions, and by creating platforms for members to collaborate and share information on their psoriasis-related projects.
Chair: André Carvalho, Brazil
Members
Olusola Ayanlowo, Nigeria
Sunil Dogra, India
Peter Foley, Australia
Maria Angeliki Gkini, United Kingdom
Jason Hawkes, United States
Seong-Jin Jo, Republic of Korea
Azura Mohd Affandi, Malaysia
The Asia-Pacific Working Group, established in 2026, focuses on fostering regional collaboration, research, and education to address the diverse needs and challenges of psoriasis patients and health care professionals across the Asia-Pacific region.
Steering Committee
Chair: Siew Eng Choon, Malaysia
Co-chair: Akimichi Morita, Japan
Members
Peter Foley, Australia
Chih-Hung Lee, Taiwan
Shekhar Neema, India
Hazel Oon, Singapore
Victoria Patiño-Guillano, Philippines
Yuling Shi, China
The Digital Health Working Group aims to enhance psoriasis care by developing and promoting best practices for using innovative digital technologies to educate practitioners, improve patient outcomes, and increase operational efficiency.
Chair: Andrew Blauvelt, United States
Co-chair: George Han, United States
Members
Daniela Armijo, Chile
Kevin Cooper, United States
Lucas Galimany, Chile
Netsanet Gebeyehu, Ethiopia
Paolo Gisondi, Italy
Mohammad Huq, Bangladesh
Satveer Mahil, United Kingdom
Alexander Navarini, Switzerland
Lev Pavlovsky, Israel
Dharshini Sathishkumar, India
Ron Vender, Canada
The Disease Severity Working Group focuses on standardizing the assessment of psoriasis severity through expert collaboration, aiming to improve diagnostic accuracy, treatment approaches, and patient care by developing metrics consistent across clinical and research environments.
Chair: Lone Skov, Denmark
Co-chair: Tiago Torres, Portugal
Members
Pravit Asawanonda, Thailand
Andrew Blauvelt, United States
Álvaro González-Cantero, Spain
Rudi Chandra, Indonesia
Cesar González, Colombia
Benjamin Hidalgo Matlock, Costa Rica
Julia-Tatjana Maul, Switzerland
Filip Rob, Czech Republic
The Diverse Skin Tones Working Group focuses on addressing the unique dermatological needs and challenges of individuals with diverse skin affected by psoriasis, aiming to enhance diagnostic and treatment capabilities and collaborating on related activities with various dermatology and patient associations.
Chair: Mahira El Sayed, Egypt
Co-chair: Murlidhar Rajagopalan, India
Members
Andrew Alexis, United States
Nejib Doss, Tunisia
Maria-Angeliki Gkini, United Kingdom
Chris Griffiths, United Kingdom
Elise Kleyn, United Kingdom
Mark Lebwohl, United States
Angela Londoño, Colombia
Mohammad Rafiqul Mowla, Bangladesh
Mio Nakamura, United States
Junko Takeshita, United States
Vermén Verallo-Rowell, Philippines
The IPC Early Career Steering Committee supports the Early Career Membership and the IPC Junior Councilor Programs. The committee ensures both efforts are aligned with IPC’s mission and provide meaningful engagement, education, collaboration, and professional development opportunities for early-career individuals interested in psoriasis.
Chair: Maria-Angeliki Gkini, United Kingdom
Co-chair: Fernando Valenzuela, Chile
Members
Deepak Balak, Netherlands
Nicholas Brownstone, United States
Netsanet Gebeyehu, Ethiopia
Natalia Merino, Peru
Rebecca Nguyen, Australia
Josep Riera-Monroig, Spain
Jensen Yeung, Canada
The Editorial Committee oversees the creation and curation of medical and scientific content for IPC's digital platforms, ensuring high editorial standards and contributing to various publications, including regular commentaries on topical issues in the field.
Chair: Lluís Puig, Spain
Co-chair: Jason Hawkes, United States
Members
José-Manuel Carrascosa, Spain
Chayada Chaiyabutr, Thailand
Francis Lai, Australia
Leandro Leite, Brazil
Matías Maskin, Argentina
Juul van den Reek, Netherlands
Matthew Vesely, United States
The Fellowship Advisory Committee aligns IPC's Fellowship program with its strategic goals, providing oversight on curriculum planning, application review, and alumni engagement to enhance program outcomes and maintain continuous improvement.
Chair: Joel Gelfand, United States
Members
Priscilla Angwenyi, Kenya
Daniela Armijo, Chile
Cristina Echeverría, Argentina
Wilson Liao, United States
Andrew Pink, United Kingdom
Patricia Tinio, Philippines
Fernando Valenzuela, Chile
The Guidelines Task Force is dedicated to conducting a global needs assessment to understand and improve the development and use of psoriasis treatment guidelines, culminating in actionable recommendations for IPC implementation.
Chair: Catherine Smith, United Kingdom
Co-chair: Alexander Nast, Germany
Members
André Carvalho, Brazil
Colby Evans, United States
Kathleen Gallant, IFPA, United States
The multi-phase consensus process is led jointly by IPC and GRAPPA. It includes a global Steering Committee and Working Group, bringing together dermatology and rheumatology perspectives along with patient input to establish clear definitions, address gaps in terminology, and identify research and clinical management priorities. The key output will be consensus definitions for difficult-to-treat and treatment-refractory psoriasis..
Chair: Lone Skov, Denmark
IPC Steering Committee Members
Manuel Franco, Colombia
George Han, United States
Josep Riera-Monroig, Spain
Yuling Shi, China
IPC Working Group Members
Marwa Amer, Egypt
Deepak Balak, Netherlands
Mohammad Samiul Huq, Bangladesh
Jo Lambert, Belgium
Leandro Leite, Brazil
Wilson Liao, United States
Angela Londono-Garcia, Colombia
Jennifer Lavina Ngo, Philippines
Ronald Vender, Canada
Claus Zachariae, Denmark
Learn more about this initiative.
The Emerging Infectious Diseases Task Force actively monitors and addresses the impact of infectious diseases on psoriasis treatment and management, updating IPC guidelines and formulating responses to emergent issues as necessary.
Chair: Joel Gelfand, United States
Members
André Carvalho, Brazil
Hervé Bachelez, France
Mahira El Sayed, Egypt
Lluís Puig, Spain
Catherine Smith, United Kingdom
The Latin American Working Group, established in 2011, focuses on fostering collaboration, research, and advocacy to address the unique needs and challenges of psoriasis patients and health care professionals in Latin America, particularly tackling issues like limited healthcare resources and access to biologics through symposia and publications on significant clinical topics.
Chair: André Carvalho, Brazil
Chair: Claudia de la Cruz, Chile
Co-chair: Fernando Valenzuela, Chile
Members
Councilors
Daniela Armijo, Chile
Jaquelini Barboza da Silva, Brazil
Juan Raul Castro Ayarza, Colombia
Paola Cardeñas, Colombia
Edgardo Chouela, Argentina
Romina Contreras, Paraguay
Cristina Echeverría, Argentina
Manuel Franco, Colombia
César Gonzalez, Colombia
Benjamin Hidalgo Matlock, Costa Rica
Leandro Leite, Brazil
Angela Londoño, Colombia
Renata Magalhães, Brazil
Matías Maskin, Argentina
Nancy Podoswa, Mexico
Ricardo Romiti, Brazil
Enrique Rivas, Guatemala
Maria Victoria Suarez Restrepo, Brazil
Margarita Velásquez, Colombia
Jr. Councilors
Lucas Galimany, Chile
Natalia Merino, Peru
Sonia Chavez-Alvarez, Mexico
María Julia Cura, Argentina
The Pediatric Psoriasis Working Group is established to identify, prioritize, and address key gaps in diagnosing, treating, managing, and understanding psoriasis in children and adolescents.
Chair: Amy Paller, United States
Co-Chair: Marieke Seyger, Netherlands
Members
Cristina Bertoli, Italy
Kelly Cordoro, United States
Mona El-Kalioby, Egypt
Paula Luna, Argentina
Renata Magalhaes, Brazil
Emmanuel Mahé, France
Ruth Murphy, United Kingdom
Towhida Noor, Bangladesh
Vimal Prajapati, Canada
Enrique Rivas, Guatemala
Dharshini Sathishkumar, India
Raquel Vaz, Sweden, IFPA Representative
Marijana Vičić, Croatia
The Research Committee will drive IPC's research goals by developing new programs to enhance researcher representation and create virtual collaboration opportunities to facilitate knowledge exchange within the network.
Chair: Johann Gudjonsson, United States
Co-chair: Curdin Conrad, Switzerland
Members
Hervé Bachelez, France
Elke de Jong, Netherlands
María Julia Cura, Argentina
Albert Duvetorp, Sweden
Antonios Kolios, Switzerland
Chih-Hung Lee, Taiwan
Yukari Okubo, Japan
Hazel Oon, Singapore
Alison Treichel, United States
Margarita Velásquez, Colombia
Nicole Ward, United States
The Symposia Committee oversees the strategic planning and quality of IPC symposia at global congresses, ensuring alignment with organizational goals and delivering high-quality content on the latest advancements in psoriasis research and care to health care professionals.
Chair: Johann Gudjonsson, United States
Co-chair: Jo Lambert, Belgium
Members
Ashar Dhana, South Africa
Cristina Echeverría, Argentina
Satveer Mahil, United Kingdom
Akimichi Morita, Japan
Shekhar Neema, India
Alex Tsoi, United States
Lily Lyralin Tumalad
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
